Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats

Archives of Toxicology

Volumn 79, Issue 9, 2005, Pages 493-499

  Saad, Sherif Y ^a   Najjar, Tawfeeg A O ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Cyclosporin A; Diabetes; Nephrotoxicity and vanadyl sulphate; Streptozotocin

Indexed keywords

BILIRUBIN; CHOLESTEROL; CREATINE; CYCLOSPORIN A; DRINKING WATER; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYALIN; INSULIN DERIVATIVE; MALONALDEHYDE; NITRATE; NITRITE; NITROGEN; STREPTOZOCIN; TAP WATER; TRIACYLGLYCEROL; UREA; VANADYL SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; DOSE RESPONSE; DRINKING; DRUG EFFECT; ENZYME ACTIVITY; GLOMERULUS; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; ISOLATED KIDNEY; KIDNEY HYPERTROPHY; KIDNEY INJURY; KIDNEY MASS; KIDNEY PARENCHYMA; KIDNEY TUBULE NECROSIS; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; RAT STRAIN; STREPTOZOCIN DIABETES; TIME; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

ANIMALS; CYCLOSPORINE; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MALONDIALDEHYDE; ORGAN SIZE; RATS; RATS, WISTAR; VANADIUM COMPOUNDS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 25644461109     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-005-0663-7     Document Type: Article

References (43)

1. Agarwal R (2003) Pro-inflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade. Am J Physiol Renal Physiol 284:F863-F869
2. Anand-Srivastava MB, McNeill JH, Yang XP (1995) Reversal of defective G-proteins and adenylyl cyclase/camp signal transduction in diabetic rats by vanadyl sulphate therapy. Mol Cell Biochem 153:113-119
3. Asai T, Nakatani T, Yamanaka S, Tamada S, Kishimoto T, Tashiro K, Nakao T, Okamura M, Kim S, Iwao H, Miura K (2002) Magnesium supplementation prevents experimental chronic cyclosporine A nephrotoxicity via renin-angiotensin system independent mechanism. Transplantation 74:784-791
4. Assan R, Blanchet F, Feutren G, Timsit J, Larger E, Boitard C, Amiel C, Bach JF (2002) Normal renal function 8 to 13 years after cyclosporine A therapy in 285 diabetic patients. Diabetes Metab Res Rev 18:464-472
5. Barnes P, Karin M (1997) Nuclear factor-kB a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071
6. Bonsnes RW, Taussky HN (1945) On the colorimetric determination of creatinine by Jaffe reaction. J Biol Chem 158:581-591
7. Cattran D, Neogi T, Sharma R, Mc Carthy ET, Savin VJ (2003) Serial estimates of serum permeability activity and clinical correlates in patients with native focal segmental glomerulosclerosis. J Am Soc Nephrol 14:448-453
8. Christopher J, Jaffa AA (2002) Diabetes modulates the expression of glomerular kinin receptors. Int Immunopharmacol 2:1771-1779
9. Colell A, Garcia-Ruiz C, Mari M, Fernandez-Checa JC (2004) Mitochondrial permeability transition induced by reactive oxygen species is independent of cholesterol-regulated membrane fluidity. FEBS Lett 560:63-68
10. Dai S, Thompson KH, McNeill JH (1994) One-year treatment of streptozotocin-induced diabetic rats with vanadyl sulphate. Pharmacol Toxicol 74:101-109
11. Denghani GA, Ahmadi S, Omrani GR (1997) Effects of vanadyl sulphate on glucose homeostasis in severe diabetes induced by streptozotocin in rats. Indian J Med Res 106:481-485
12. Eberhard R, Dikow R (2002) Angiotensin receptors antagonists in patients with nephropathy due to type 2 diabetes. Ann Med 34:507-13
13. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70-71
14. Ferrero ME, Marni A, Parise M, Solari PC, Corsi M, Gaja G (1992) Cyclosporine-induced insulin release in rats is related to an increase in plasma lipid levels. Transpl Int 1(Suppl):S494-S496
15. Ha H, Kim KH (1995) Role of oxidative stress in the development of diabetic nephropathy. Kidney Int 48(Suppl 51):S18-S21
16. Hallett CJ, Cook JG (1971) Reduced nicotinamide adenine dinucleotide-coupled reaction for emergency blood urea estimation. Clin Chim Acta 35:33-37
17. Hirano T, Kawamura T, Fukuda S, Kohsaka S, Yoshikawa N, Yoshida M, Oka K (2003) Implication of cholesterol in cyclosporine pharmacodynamics in minimal change nephritic syndrome. Clin Pharmacol Ther 74:581-590
18. Hoshiyama M, Li B, Yao J, Harada T, Morioka T, Oite T (2003) Effect of high glucose on nitric oxide production and endothelial nitric oxide synthase protein expression in human glomerular endothelial cells. Nephron Exp Nephrol 95:e62-e68
19. Hunt JV, Wolff SP (1991) Oxidative glycation and free radical production: a causal mechanism of diabetic complications. Free Radic Res Commun 1:115-123
20. Jaspers I, Samet JM, Erzurum S, Reed W (2000) Vanadium-induced kappa B-dependent transcription depends upon peroxide-induced activation of the p38 mitogen-activated protein kinase. Am J Respir Cell Mol Biol 23:95-102
21. Kanna PS, Mahendrakumar CB, Chankraborty T, Hemalatha P, Banerjee P, Chatterjee M (2003) Effect of vanadium on colonic aberrant crypt foci induced in rat by 1,2-dimethyl hydrazine. World J Gastroenterol 9:1020-1027
22. Kedziora-Kornatowska K, Szram S, Kornatowski T, Szadujkis-Szadurski L, Kedziora J, Bartosz G (2003) Effect of vitamin E and vitamin C supplementation on antioxidative state and renal glomerular basement membrane thickness in diabetic kidney. Nephron Exp Nephrol 95:e134-e143
23. Kim T, Callahan SM, Wasan KM, Brunner LJ (2003) Effect of high-density lipoproteins associated cyclosporine on hepatic metabolism and renal function. PDA J Pharm Sci Technol 57:341-50
24. Kotamraju S, Hogg N, Joseph J, Keefer LK, Kalyanaraman B (2001) Inhibition of oxidized low-density lipoprotein-induced apoptosis in endothelial cells by nitric oxide. J Bio Chem 276:17316-17323
25. Lubec B, Aufricht C, Amann G, kitzmuller E, Hoger H (1997) Arginine reduces kidney collagen accumulation, cross-linking, lipid peroxidation, glycoxidation, kidney weight and albuminuria in the diabetic kk mouse. Nephron 75:213-218
26. Makibayashi K, Fukatsu A, Kita T (2002) Complete remission of minimal change nephrotic syndrome with type 2 diabetes mellitus treated by microemulsion formulation of cyclosporine and fluvastatin. Nippon Jinzo Gakkai Shi 44:109-113
27. Mansour M, Daba MH, Gado A, Al-Rikabi A, Al-Majed A (2002) Protective effect of L-arginine against nephrotoxicity induced by cyclosporine in normal rats. Pharmacol Res 45:441-446
28. Mentha G, Schopfer C, Vadas L, Belenger J, Morel P, Criado F, Rohner A (1992) Influence of hepatic dysfunction on cyclosporine metabolism in pig. Transplant Int 5(Suppl):S511-S513
29. Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62-71
30. Ohkawa H, Ohishi N, Yagi K (1979) Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
31. Okumura M, Imanishi M, Okamaura M, Hosoi M, Okada N, Konishi Y, Morikawa T, Miura K, Nakatani T, Fujii S (2003) Role for thromboxane A2 for glomerular thrombi in nephropathy with type 2 diabetic rats. Life Sci 72:2695-2702
32. Olyaei AJ, de Mattos AM, Bennett WM (2001) Nephrotoxicity of immunosuppressive drugs: new insight preventive strategies. Opin Crit Care 7:384-389
33. Padi SS, Chopra K (2002a) Salvage of cyclosporine A-induced oxidative stress and renal dysfunction by carvedilol. Nephron 92:685-692
34. Padi SS, Chopra K (2002b) Selective angiotensin II type 1 receptors blockade ameliorates cyclosporine nephrotoxicity. Pharmacol Res 45:413-420
35. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158-169
36. Reul BA, Amin SS, Buchet JP, Ongemba LN, Crans DC, Brichard SM (1999) Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats. Br J Pharmacol 126:467-477
37. Shafrir E, Spielman S, Nachliel I, Khamaisi M, Bar-On H, Ziv E (2001) Treatment of diabetes with vanadium salts: general overview and amelioration nutritionally induced diabetes in the Psammomys obesus gerbil. Diabetes Metab Res Rev 17:55-66
38. Stacchiotti A, Rezzani R, Angoscini P, Crosetti G, Bianchi R (2001) Distribution of heat shock proteins in kidneys of rats after immunosuppressive treatment with cyclosporine A. Acta Histochem 103:167-177
39. Strong ML, Ueda CT (1997) Effects of low and high density lipoproteins on renal cyclosporine A and cyclosporine G disposition in the isolated perfused rat kidney. Pharmacol Res 14:1466-1471
40. Vivian EM, Rubinstein GM (2002) Pharmacologic management of diabetic nephropathy. Clin Ther 24:1741-1756
41. Vos IH, Joles JA, Schurink M, Weckbecker G, Stojanovic T, Rabelink TJ, Grone HJ (2000) Inhibition of inducible nitric oxide synthase improves graft function and reduces tubulo-interstitial injury in renal allograft rejection. Eur J Pharmacol 391:31-38
42. Wolf G, Butzmann U, Wenzel UO (2003) The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology. Nephron Physiol 93:P3-13
43. Wrenn HT, Feichtmeir TV (1956) The quantitation of albumin based on dye linear binding capacity. Am J Clin Pathol 26:960-968